PTPRC and neoplasm: The analysis of the 21 BM samples obtained from nine patients with non-neoplastic diseases and 12 patients with acute lymphoblastic leukemia revealed no cells with the CD56+/CD90+/CD45−/GD2− or CD56+/CD90+/CD45−/GD2+ phenotypes.